BEIJING, Sept. 15, 2025 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WiMi) (“WiMi” or the “Company”), a leading global Hologram Augmented Reality (“AR”) Technology provider, today announced that they are actively exploring Scalable Quantum… Read More »WiMi Lays Out Scalable Quantum Convolutional Neural Network to Enhance Image Classification Accuracy and Efficiency
Kredete has raised a $22 million Series A funding round led by AfricInvest via their Cathay AfricInvest Innovation Fund (CAIF) and Financial Inclusion Vehicle (FIVE), alongside Partech, and with participation from Polymorphic Capital. New York,… Read More »Kredete raises a $22M Series A round to expand credit-building infrastructure with stablecoin transfers to Africa
New York, NY, Sept. 15, 2025 (GLOBE NEWSWIRE) — $SON (a cryptocurrency inspired by the famous “are ya winning, son?” internet meme) announced today that you can now buy $SON with Apple Pay, Paypal, Mastercard, or… Read More »Solana Memecoin $SON is First-Ever Meme to Utilize New Payment Flow with Moonpay & Moongate
LOS ANGELES, Sept. 15, 2025 (GLOBE NEWSWIRE) — Nano Banana AI, a top-notch leading AI tool platform, is making waves by launching its AI Editing Tool, which provides creators with consistency and style. With the… Read More »Nano Banana AI Launches AI Editing Tool, Making Creativity Simple and Reliable
RANCHO CUCAMONGA, Calif., Sept. 15, 2025 /PRNewswire/ — FEELINGIRL, a brand renowned for its technology-driven shapewear, once again took center stage with the FEELINGIRL Bra collection. Dedicated to enhancing women’s confidence, FEELINGIRL is committed to… Read More »FEELINGIRL Honored at MUSE Design Awards for Redefining Post-Surgery Shapewear
Together we’re unlocking the true potential of clinical trial lab data, bringing faster insights, smarter decisions, and better outcomes. JOHNSON CITY, Tenn. and HOUSTON, Sept. 15, 2025 /PRNewswire/ — LabConnect, a leading global provider of… Read More »LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights